Cytec Industries Stock Downgraded (CYT)
NEW YORK (TheStreet) -- Cytec Industries (NYSE:CYT) has been downgraded by TheStreet Ratings from buy to hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and reasonable valuation levels. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, unimpressive growth in net income and poor profit margins. Highlights from the ratings report include:
- Despite its growing revenue, the company underperformed as compared with the industry average of 21.7%. Since the same quarter one year prior, revenues rose by 13.6%. This growth in revenue does not appear to have trickled down to the company's bottom line, displayed by a decline in earnings per share.
- The current debt-to-equity ratio, 0.34, is low and is below the industry average, implying that there has been successful management of debt levels. To add to this, CYT has a quick ratio of 1.59, which demonstrates the ability of the company to cover short-term liquidity needs.
- CYTEC INDUSTRIES INC's earnings per share declined by 29.4% in the most recent quarter compared to the same quarter a year ago. This company has reported somewhat volatile earnings recently. But, we feel it is poised for EPS growth in the coming year. During the past fiscal year, CYTEC INDUSTRIES INC turned its bottom line around by earning $2.84 versus -$0.06 in the prior year. This year, the market expects an improvement in earnings ($3.31 versus $2.84).
- Net operating cash flow has significantly decreased to $15.40 million or 82.15% when compared to the same quarter last year. In addition, when comparing to the industry average, the firm's growth rate is much lower.
- Despite any intermediate fluctuations, we have only bad news to report on this stock's performance over the last year: it has tumbled by 37.68%, worse than the S&P 500's performance. Consistent with the plunge in the stock price, the company's earnings per share are down 29.41% compared to the year-earlier quarter. Although its share price is down sharply from a year ago, do not assume that it can now be tagged as cheap and attractive. The reality is that, based on its current price in relation to its earnings, CYT is still more expensive than most of the other companies in its industry.
Latest Headlines about CYT
-
Cytec Industries (CYT) Shares Cross Below 200 DMA
11:30AM 05/23/13
-
Cytec Industries (CYT) Shares Cross Below 200 DMA
11:25AM 04/19/13
-
5 Relative Strength Trades Flashing Buy
11:23AM 12/04/12
-
Cytec Industries Management Discusses Q2 2012 Results - Earnings Call Transcript
02:20PM 07/20/12
-
Cytec Industries' CEO Discusses Q1 2012 Results - Earnings Call Transcript
02:50PM 04/20/12
-
7 Hot Stocks on Traders' Radars
03:09PM 04/12/12
-
Cytec Closes On Star Orechem Asset Deal For $37M
01:36PM 04/02/12
Latest from TheStreet Wire
-
Abbott Laboratories (ABT): Today's Featured Health Services Laggard
05:22PM 06/19/13
-
Petroleo Brasileiro SA Petrobras (PBR): Today's Featured Basic Materials Laggard
05:01PM 06/19/13
-
Microsoft Corporation (MSFT): Today's Featured Computer Software & Services Laggard
05:01PM 06/19/13
-
Target Corp (TGT): Today's Featured Services Laggard
05:01PM 06/19/13
-
Teck Resources Ltd (TCK): Today's Featured Metals & Mining Laggard
05:01PM 06/19/13
-
United Technologies Corp (UTX): Today's Featured Industrial Laggard
05:01PM 06/19/13
-
Texas Instruments Inc. (TXN): Today's Featured Electronics Laggard
05:01PM 06/19/13
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
